APPLICATION OF THE DRUG "BAKTIZEV" IN THE COMPREHENSIVE TREATMENT OF PURULENT INFLAMMATORY DISEASES OF THE MAXILLOFACIAL REGION

The number of patients with pyoinflammatory diseases of the maxillofacial region, despite the active introduction of new bactericidal and bacteriostatic drugs, is increasing [1, 2]. In addition, purulent-inflammatory diseases of the maxillofacial region (MFO) can lead to the development of such formidable complications as acute odontogenic mediastinitis, meningitis, sepsis, thrombosis of the dura mater sinuses. Usually mixed odontogenic infection of microflora, facultative bacteria are mainly green streptococci (in particular, Streptococcus mutans , Streptococcus milleri ), as well as non-spore- forming anaerobes ( Peptostreptococcus spp ., Fusobacterium spp ., Actinomyces spp .). Literature data of foreign and domestic authors show that in case of odontogenic inflammatory diseases, Staphylococcus spp . (15%), Streptococcus spp . (6%) and obligate anaerobic bacteria (79%). Anaerobes are represented by gram-positive microorganisms - Bacteroides spp ., Fusobacterium spp ., Gram-positive cocci (N.G. Korotkikh, G.V. Toboev . - Voronezh: SOIGSI, 2010). Thus , the literature data have shown that the problem under study remains an urgent problem in the practice of maxillofacial surgery

Перевод пока недоступен